Literature DB >> 16629864

Predictors of gastric emptying in Parkinson's disease.

O Goetze1, A B Nikodem, J Wiezcorek, M Banasch, H Przuntek, T Mueller, W E Schmidt, D Woitalla.   

Abstract

Predictors of gastric emptying (GE) in patients with idiopathic Parkinson's disease (PD) of a solid and liquid meal are not well defined. For measurement of GE 80 patients with PD were randomly assigned to receive either a solid meal (250 kcal) containing 13C-octanoate (n = 40) or a liquid meal (315 kcal) with 13C-acetate (n = 40). All patient groups were off medication affecting motility and were matched for age, gender, body mass index, disease duration and severity, using Unified Parkinson's Disease Rating Scale (UPDRS). Gastric emptying was compared with a healthy control group (n = 40). Multiple regression analysis was used to determine predictors of gastric emptying. Exactly 88% and 38% of PD patients had delayed GE of solids and liquids respectively. Solid and liquid emptying was similar in women and men. There were no differences in GE in PD patients < 65 years of age when compared with patients > or = 65 years. Multiple regression analysis showed that motor handicaps such as rigour and action tremor are independent predictors of solid GE (r = 0.68, P < 0.001). The severity of motor impairment, but not any other neurological symptom, as assessed by UPDRS is associated with gastroparesis in PD and solid emptying is more likely to be delayed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16629864     DOI: 10.1111/j.1365-2982.2006.00780.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  40 in total

1.  Mice overexpressing wild-type human alpha-synuclein display alterations in colonic myenteric ganglia and defecation.

Authors:  L Wang; I Magen; P-Q Yuan; S R Subramaniam; F Richter; M-F Chesselet; Y Taché
Journal:  Neurogastroenterol Motil       Date:  2012-07-11       Impact factor: 3.598

Review 2.  Gut dysfunction in Parkinson's disease.

Authors:  Adreesh Mukherjee; Atanu Biswas; Shyamal Kumar Das
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

Review 3.  Gastrointestinal features of Parkinson's disease.

Authors:  Leslie J Cloud; James G Greene
Journal:  Curr Neurol Neurosci Rep       Date:  2011-08       Impact factor: 5.081

4.  Unchanged gastric emptying and visceral perception in early Parkinson's disease after a high caloric test meal.

Authors:  L Epprecht; S R Schreglmann; O Goetze; D Woitalla; C R Baumann; D Waldvogel
Journal:  J Neurol       Date:  2015-06-06       Impact factor: 4.849

5.  Gastrointestinal function in dementia with Lewy bodies: a comparison with Parkinson disease.

Authors:  Hirokazu Doi; Ryuji Sakakibara; Masayuki Masuda; Fuyuki Tateno; Yosuke Aiba; Masahiko Kishi; Tomonori Yamanishi; Tatsuya Yamamoto; Katsuyoshi Matsuoka
Journal:  Clin Auton Res       Date:  2019-02-11       Impact factor: 4.435

6.  Gastric dysregulation induced by microinjection of 6-OHDA in the substantia nigra pars compacta of rats is determined by alterations in the brain-gut axis.

Authors:  Luca Toti; R Alberto Travagli
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-10-02       Impact factor: 4.052

7.  Gastric emptying, postprandial blood pressure, glycaemia and splanchnic flow in Parkinson's disease.

Authors:  Laurence G Trahair; Thomas E Kimber; Katerina Flabouris; Michael Horowitz; Karen L Jones
Journal:  World J Gastroenterol       Date:  2016-05-28       Impact factor: 5.742

Review 8.  Oral and infusion levodopa-based strategies for managing motor complications in patients with Parkinson's disease.

Authors:  Angelo Antonini; K Ray Chaudhuri; Pablo Martinez-Martin; Per Odin
Journal:  CNS Drugs       Date:  2010-02       Impact factor: 5.749

Review 9.  [Gastrointestinal dysfunction in idiopathic Parkinson's disease].

Authors:  K Del Tredici; W H Jost
Journal:  Nervenarzt       Date:  2012-10       Impact factor: 1.214

10.  Levodopa/carbidopa and entacapone in the treatment of Parkinson's disease: efficacy, safety and patient preference.

Authors:  Thomas Müller
Journal:  Patient Prefer Adherence       Date:  2009-11-03       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.